Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03682055
Title Phase 1/2a Study of VK-2019 in Patients With Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma (NPC)
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Cullinan Apollo Corporation
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA

Facility Status City State Zip Country Details
Stanford University, School of Medicine, Stanford Cancer Institute Stanford California 94305 United States Details
The University of Texas - MD Anderson Cancer Center Houston Texas 77030 United States Details
Sun Yat Sen University Cancer Center Guangzhou Guangdong 510060 China Details
Institut Gustave Roussy Villejuif 94800 France Details
Hong Kong University - Queen Mary Hospital Hong Kong Hong Kong Details
National Cancer Centre Singapore Singapore 169610 Singapore Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field